X4 Pharmaceuticals Inc (XFOR) Ownership

1.15 ↑0.07 (6.48%)
As of May 3, 2024, 3:59pm EST.

Institutional Ownership

Bain Capital Life Sciences Investors, LLC is the biggest individual institutional holder of X4 Pharmaceuticals Inc (XFOR), owning a total of 16.9 million shares. Combined, the top 44 institutional holders of XFOR own 76.09% of the company with a total of 125.9 million shares.

In the latest ownership report on December 31st 2023, the top 44 institutional holders increased their combined ownership of XFOR by 5.6 million shares. 9 institutions bought 8,078,467 total additional shares and increased their ownership by an average of 41.50%. However 5 institutions sold 2,483,356 total shares and decreased their ownership by an average of 15.74%.

Overall this is a positive sign as the number of shares owned by the top 20 institutional holders of X4 Pharmaceuticals increased by a net total of 5,595,111 in the latest quarter.

Institution Ownership Chart

Your browser does not support this chart.

Latest Institutional Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Bain Capital Life Sciences Investors, LLC10.073%5.985%16,915,784955,1962023-12-31
NEA Management Company, LLC8.924%0.000%14,986,79302023-12-31
BlackRock Inc5.012%3.196%8,417,524260,6832023-12-31
Vanguard Group Inc4.769%2.353%8,008,865184,1482023-12-31
Orbimed Advisors, LLC4.248%0.000%7,133,51502023-12-31
Kingdon Capital Management LLC4.137%252.000%6,947,3664,973,6832023-12-31
Adage Capital Partners Gp LLC2.546%0.000%4,276,31502023-12-31
Sio Capital Management, LLC2.137%38.069%3,588,427989,4242023-12-31
Perceptive Advisors LLC2.111%0.000%3,545,45402023-12-31
AXA SA1.830%-2.361%3,073,532-74,3332023-12-31
Geode Capital Management, LLC1.669%6.036%2,802,449159,5342023-12-31
State Street Corporation1.446%2.067%2,427,78949,1632023-12-31
Armistice Capital, LLC1.153%-17.827%1,936,000-420,0002023-12-31
UBS O'Connor LLC1.038%11.734%1,743,038183,0522023-12-31
Millennium Management LLC0.991%-53.973%1,664,317-1,951,6472023-12-31
Northern Trust Corp0.633%-0.441%1,062,985-4,7082023-12-31
GSA Capital Partners LLP0.563%52.058%945,171323,5842023-12-31
Parkman Healthcare Partners LLC0.457%-4.084%767,332-32,6682023-12-31

Top Institutions

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Bain Capital Life Sciences Investors, LLC10.073%5.985%16,915,784955,1962023-12-31
NEA Management Company, LLC8.924%0.000%14,986,79302023-12-31
BlackRock Inc5.012%3.196%8,417,524260,6832023-12-31
Vanguard Group Inc4.769%2.353%8,008,865184,1482023-12-31
Polar Capital Holdings PLC4.483%0.000%7,500,0007,500,0002023-09-30
Orbimed Advisors, LLC4.248%0.000%7,133,51502023-12-31
Kingdon Capital Management LLC4.137%252.000%6,947,3664,973,6832023-12-31
Tri Locum Partners LP3.735%52.380%6,247,5002,147,5572023-09-30
Stonepine Capital Management Llc3.152%14.514%5,273,685668,4222023-09-30
Adage Capital Partners Gp LLC2.546%0.000%4,276,31502023-12-31
Sio Capital Management, LLC2.137%38.069%3,588,427989,4242023-12-31
Perceptive Advisors LLC2.111%0.000%3,545,45402023-12-31
AXA SA1.830%-2.361%3,073,532-74,3332023-12-31
Geode Capital Management, LLC1.669%6.036%2,802,449159,5342023-12-31
State Street Corporation1.446%2.067%2,427,78949,1632023-12-31
CVI Holdings LLC1.399%0.000%2,300,3152,300,3152023-06-30
Armistice Capital, LLC1.153%-17.827%1,936,000-420,0002023-12-31
Citadel Advisors Llc1.071%-41.483%1,798,628-1,275,0712023-09-30
UBS O'Connor LLC1.038%11.734%1,743,038183,0522023-12-31
Millennium Management LLC0.991%-53.973%1,664,317-1,951,6472023-12-31
Cormorant Asset Management, LLC0.991%0.000%1,628,98002023-03-31
Bvf Inc1.103%58.944%1,347,650499,7712022-12-31
Northern Trust Corp0.633%-0.441%1,062,985-4,7082023-12-31
AIGH Capital Management, LLC0.821%0.000%997,71902022-09-30
Schonfeld Strategic Advisors LLC0.598%-5.140%983,700-53,3002023-06-30
GSA Capital Partners LLP0.563%52.058%945,171323,5842023-12-31
Lynwood Capital Management Inc.0.547%-58.239%900,000-1,255,1002023-03-31
Ghost Tree Capital, LLC0.517%-15.000%850,000-150,0002023-03-31
Parkman Healthcare Partners LLC0.457%-4.084%767,332-32,6682023-12-31
Marshall Wace Asset Management Ltd0.428%0.000%704,351704,3512023-06-30
Point72 Asset Management, L.P.0.387%0.000%650,00002023-09-30
JPMorgan Chase & Co0.381%423.459%626,047506,4492023-03-31
EAM Investors, LLC0.345%0.000%567,801567,8012023-06-30
SCOGGIN LLC0.295%0.000%484,796484,7962023-03-31
Bank of New York Mellon Corp0.291%179.351%478,229307,0362023-06-30
Simplify Asset Management Inc.0.243%0.000%400,000400,0002023-03-31
Ikarian Capital, LLC0.212%0.000%349,13302023-03-31
New Leaf Venture Partners, L.L.C.0.211%0.000%335,00002023-03-31
SV Life Sciences Advisers, LLC0.256%0.000%311,49002022-09-30
Worth Venture Partners, LLC0.206%0.000%250,14402022-09-30
Renaissance Technologies Corp0.199%12.026%242,19426,0002022-09-30
BOOTHBAY FUND MANAGEMENT, LLC0.260%27.667%179,96339,0002022-06-30
Susquehanna International Group, LLP0.124%0.000%150,597150,5972022-09-30
Stifel Financial Corp0.098%-3.040%67,483-2,1162022-06-30

Mutual Fund Ownership

Polar Capital Biotech S Inc is the biggest individual fund holder of X4 Pharmaceuticals Inc (XFOR), owning a total of 7.4 million shares. Combined, the top 47 mutual fund holders of XFOR own 24.25% of the company with a total of 40.4 million shares.

In the latest ownership report on March 31st 2024, the top 47 fund holders increased their combined ownership of XFOR by 352 thousand shares. 3 funds bought 397,815 total additional shares and increased their ownership by an average of 1.86%. However 1 funds sold 46,000 total shares and decreased their ownership by an average of 11.84%.

Overall this is a positive sign as the number of shares owned by the top 20 mutual funds holding X4 Pharmaceuticals increased by a net total of 351,815 in the latest report.

Mutual Funds Chart

Your browser does not support this chart.

Latest Mutual Fund Ownership Changes

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Vanguard Institutional Extnd Mkt Idx Tr1.100%2.168%1,846,64339,1862024-03-31
State St Russell Sm/Mid Cp® Indx NL Cl C0.423%0.000%710,60002024-03-31
Vanguard Russell 2000 ETF0.272%3.402%457,34915,0492024-03-31
State St Russell Sm Cap® Indx SL Cl I0.270%0.000%453,80002024-03-31
Simplify Propel Opportunities ETF0.238%0.000%400,00002024-03-31
BlackRock Extended Equity Market K0.205%0.000%343,580343,5802024-03-31
Royce Micro Cap Trust0.204%-11.845%342,363-46,0002024-03-31
Schwab Small Cap Index0.168%0.000%281,45702024-03-31

Top Mutual Funds

OwnerPercent OwnedPercent ChangeShares OwnedShare ChangeDate Reported
Polar Capital Biotech S Inc4.450%-0.747%7,444,000-56,0002023-11-30
Vanguard Total Stock Mkt Idx Inv2.993%-4.861%5,027,099-256,8502024-02-29
iShares Russell 2000 ETF1.874%4.950%3,146,282148,3802024-03-28
Vanguard Instl Ttl Stck Mkt Idx Tr1.871%6.139%3,081,349178,2082023-03-31
UTM IM GBP AXA Framlington Biotech1.757%0.000%2,949,82102024-02-29
Vanguard Institutional Extnd Mkt Idx Tr1.100%2.168%1,846,64339,1862024-03-31
MEDICAL BioHealth EUR Acc1.060%0.000%1,780,03402023-11-30
Vanguard Extended Market Index Investor0.922%0.000%1,516,16702023-08-31
Fidelity Small Cap Index0.737%1.114%1,236,86713,6232024-01-31
Fidelity® Small Cap Index0.698%0.679%1,167,3357,8692023-10-31
Fidelity® Extended Market Index0.473%12.594%791,73288,5552023-11-30
Fidelity Extended Market Index0.468%-0.482%785,941-3,8082024-02-29
APO Medical Opportunities R0.427%0.000%717,62302024-02-29
State St Russell Sm/Mid Cp® Indx NL Cl C0.423%0.000%710,60002024-03-31
iShares Russell 2000 Value ETF0.376%16.131%631,00087,6492024-03-28
EAM Ultra Micro Cap0.345%0.000%567,41602023-07-31
iShares Russell 2000 Growth ETF0.318%-0.116%533,310-6202024-03-28
Vanguard Russell 2000 ETF0.272%3.402%457,34915,0492024-03-31
State St Russell Sm Cap® Indx SL Cl I0.270%0.000%453,80002024-03-31
State St Russell Sm Cap® Indx NL Cl C0.276%0.000%453,80002023-09-30
Simplify Propel Opportunities ETF0.238%0.000%400,00002024-03-31
BlackRock Advantage Small Cap Core Instl0.222%-0.263%365,191-9622023-07-31
BlackRock Extended Equity Market K0.205%0.000%343,580343,5802024-03-31
Royce Micro Cap Trust0.204%-11.845%342,363-46,0002024-03-31
NT R2000 Index Fund - NL0.185%-11.092%311,379-38,8452023-12-31
Schwab Small Cap Index0.168%0.000%281,45702024-03-31
NT R2000 Index Fund - DC - NL - 20.166%-0.800%276,869-2,2322023-09-30
iShares Micro-Cap ETF0.163%0.000%273,51402024-03-28
BlackRock Extended Mkt Composite0.158%0.817%265,9652,1542023-09-30
RIM Global Bioscience EUR0.155%0.000%258,63902023-12-31
Russell 2000 Index Non-Lendable Fund E0.131%0.000%207,772207,7722023-06-30
Fidelity® Total Market Index0.125%0.000%197,50402023-05-31
BlackRock Russell 2500™ Index F0.121%0.000%192,606192,6062023-06-30
AXA IM Wave Biotech A0.117%-8.531%186,143-17,3602023-05-31
Fidelity® Series Total Market Index0.090%0.000%142,00902023-05-31
iShares Core S&P Total US Stock Mkt ETF0.080%-0.033%126,706-422023-06-30
Vanguard Balanced Index Inv0.078%0.000%122,90802023-04-30
Vanguard Instl Ttl Stk Mkt Idx InstlPls0.076%0.000%120,73402023-05-31
NT Ext Equity Mkt Idx Fd - NL0.070%35.617%110,32228,9742023-03-31
NT Ext Equity Mkt Idx Fd - DC - NL - T20.059%41.386%93,37127,3312023-03-31
State St US Extended Mkt Indx NL Cl C0.058%20,377.800%92,15091,7002023-05-31
NT Ext Equity Mkt Idx Fd - L0.056%91.300%88,21842,1032023-03-31
Northern Trust Extended Eq Market Idx0.056%91.300%88,21842,1032023-03-31
Spartan Total Market Index Pool E0.049%65.130%60,38323,8162023-03-31
apo Medical Opportunities Institutionell0.046%0.000%56,18902023-03-31
Fidelity® NASDAQ Composite Index®0.037%0.000%45,60002023-02-28
Schwab Total Stock Market Index0.035%0.000%42,38602023-02-28

Discussions

Please log in or register to share your thoughts.